SER-109, an Oral Microbiome Therapy for Recurrent <i>Clostridioides difficile</i> Infection
Seres Therapeutics, Inc.
Paul Feuerstadt; Thomas J Louie; Bret Lashner; Elaine E L Wang; Liyang Diao; Jessica A Bryant; Matthew Sims; Colleen S Kraft; Stuart H Cohen; Charles S Berenson; Louis Y Korman; Christopher B Ford; Kevin D Litcofsky; Mary-Jane Lombardo; Jennifer R Wortman; Henry Wu; John G Auniņš; Christopher W J McChalicher; Jonathan A Winkler; Barbara H McGovern; Michele Trucksis; Matthew R Henn; Lisa von Moltke